Source: International Congress 2015 – New models for treating airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Meina Li (Parkville, Australia), Meina Li, Christine Keenan, Yuxiu Xia, Alastair Stewart. Proteome profiling reveals candidate mediators of TGF-β-induced glucocorticoid resistance. Eur Respir J 2015; 46: Suppl. 59, 3575

Member's Comments

No comment yet.

Related content which might interest you: MiR-320d: A novel anti-inflammatory miRNA up regulated by corticosteroids Source: International Congress 2015 – Latest news on miRNAs in pulmonary research Year: 2015 Gene expression changes in human bronchial epithelial cells in response to leukotriene E4 Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 Leukotriene E4 affects expression of genes involved in inflammatory, remodelling and mitogenic responses in human bronchial epithelial cells Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair Year: 2016 Glucocorticoids and indacaterol regulated gene expressions profiling in human bronchial epithelial cells Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 RNA-seq analysis of transforming growth factor-beta-induced glucocorticoid resistance in human bronchial epithelial cells Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Transcriptional analysis of the human BPIFA1/SPLUNC1 gene Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung Year: 2013 Effects of formoterol on the molecular mechanisms of corticosteroid resistance in models with high oxidative stress Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine Year: 2014 Transcriptomic profiling of Macrophages isolated from human Non-Small Cell Lung Carcinoma (NSCLC) reveals novel Macrophage subsets with distinct tumour response features Source: ERS Lung Science Conference 2016 Year: 2016 Anti-inflammatory effects of resveratrol analogues in cellular models of airway inflammation Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 Sputum supernatant profiling reveals inflammasome-associated signatures in severe asthmatics in U-BIOPRED Source: International Congress 2015 – Advances in the future treatment of severe asthma Year: 2015 Validating SIK as a novel COPD target using four different human systems Source: International Congress 2014 – Translational studies in COPD Year: 2014 Steroid resistance in COPD is associated with impaired molecular chaperone HSP90 expression by pro-inflammatory lymphocytes Source: International Congress 2016 – Mechanisms of disease Year: 2016 Estrogen-regulated miRNA-19b modulates the expression of secretory leukoprotease inhibitor in monocytes Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways Year: 2013 Glucocorticoid-induced transcriptional regulators in human airway cells and airways Source: International Congress 2016 – Studies in airway cell biology Year: 2016 Discovery of candidate proteins, PIGR and SELENBP1, as novel markers of airway diseases in COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Global gene expression analyses highlight the role of plasma membrane remodeling as a molecular functions of airway epithelium in response to interleukin-13 treatment Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 Mining common pathway deregulation profiles in lung diseases Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD) Year: 2014 Cytokine-induced glucocorticoid resistance: Effect on GILZ expression and reversal by formoterol Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Evaluation of gene expression during in vitro ciliogenesis to search for novel candidate genes in primary ciliary dyskinesia Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases Year: 2013 Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014